Nature 444 (7122), 10221023
GLP-3 is being studied in people with obesity (BMI of 30 or higher) or those who are overweight (BMI of 27 or higher) with at least one weight-related health condition like high blood pressure, high cholesterol, or prediabetes
A 2023 analysis of by NBC News found that more than nine million prescriptions for Wegovy and other injectable drugs used for weight loss were doled out during the last three months of 2022 alone
GLP1 Therapy Improves Atrial Fibrillation Outcomes After Catheter Ablation, Miller School Study Finds University of Miami Miller School of Medicine researchers found liraglutide significantly reduced AFib recurrence in overweight and obese patients, suggesting a new preablation treatment strategy
Improved Metabolic Health Beyond weight loss, Semaglutide offers additional metabolic benefits, such as better blood sugar control, reduced insulin resistance, and improvements in cholesterol levels
Morning dosing also creates a consistent routine that simplifies adherencemany people remember medications alongside morning rituals like coffee or vitamins
